Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Craig Johnson

Plastic Surgery Saint Paul, MN Medical Doctor

NPI 1043299555 CMS profile 876651

280 Smith Ave N Ste 700, Saint Paul, MN 55102

Open in the dashboard

General payments

$53,914

28 records reported · program years 2019–2025

Research payments

$475

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$44,409

6 holdings reported · through program year 2025

Through program year 2025, Craig Johnson of Saint Paul, MN is reported in the CMS Open Payments database as having received $53,914 across 28 general payments and $475 in research payments paid to them. They also declared ownership or investment interests valued at $44,409 across 6 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $124 1
2022 General $2,047 4
2021 General $16,288 7
2021 Research $475 1
2019 General $35,455 16
2025 Ownership $3,838 1
2024 Ownership $7,950 1
2023 Ownership $7,402 1
2022 Ownership $7,127 1
2021 Ownership $9,046 1
2020 Ownership $9,046 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Craig Johnson
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Craig Johnson were reported at $124. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Craig Johnson Plastic Surgery median Middle half National median
2019 $35,455 $371 $122–$1,483 $163
2020 $0 $158 $52–$438 $114
2021 $16,288 $249 $87–$752 $132
2022 $2,047 $274 $102–$793 $149
2023 $0 $299 $113–$891 $160
2024 $0 $361 $124–$1,062 $164
2025 $124 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. RTI Surgical, Inc. $33,424 10 payments
  2. RTI Surgical, Inc $18,288 10 payments
  3. Allergan Inc. $2,031 6 payments
  4. AbbVie, Inc. $124 1 payment
  5. Mentor Worldwide LLC $47 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $50,550 15 payments
  2. Travel and Lodging $2,381 4 payments
  3. Food and Beverage $982 9 payments
Products named General payments · program years 2019–2025
  1. CORTIVA ALLOGRAFT DERMIS $34,300 9 payments
  2. CORTIVA TAILORED ALLOGRAFT DERMIS $16,250 6 payments
  3. ALLODERM $2,007 4 payments
  4. ALLOGRAFT $1,124 4 payments
  5. NATRELLE SALINE-FILLED BREAST IMPLANTS $124 1 payment
  6. MENTOR MemoryGel Resterilizable Gel Sizer $47 1 payment
  7. FORTIVA PORCINE DERMIS $38 1 payment
  8. NATRELLE $24 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Novartis Pharmaceuticals Corporation $475 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

17

Median for Plastic and Reconstructive Surgery: 61

Drug cost

$103

Median for Plastic and Reconstructive Surgery: $369

Branded share of claims

100%

Median for Plastic and Reconstructive Surgery: 30%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 17 $103

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,638 Part D prescribers listed as Plastic and Reconstructive Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 69 billing codes

Paid by Medicare

$104,602

Medicare's payments for the services billed

Medicare patients

95

Average age 64

Services billed

422

50 women, 45 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 62%
Depression 47%
Arthritis 44%
Diabetes 34%
Chronic kidney disease 33%
Ischemic heart disease 31%
Cancer 26%
Atrial fibrillation 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

29 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record